¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"T80"¿¡ ´ëÇÑ Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú :
5
ÆäÀÌÁö:
2
ÄÚµå
¿µ¹®
ÇѱÛ
T80.8
Other complications following infusion, transfusion and therapeutic injection
±âŸ ÁÖÀÔ, ¼öÇ÷ ¹× Ä¡·á¿ë Áֻ翡 ÀÇÇÑ ÇÕº´Áõ
T80.6
Other serum reactions
±âŸ Ç÷û ¹ÝÀÀ
T80.4
Rh incompatibility reaction
RhÀÎÀÚ ºÎÀûÇÕ ¹ÝÀÀ
T80.9
Unspecified complications following infusion, transfusion and therapeutic injection
»ó¼¼ºÒ¸íÀÇ ÁÖÀÔ, ¼öÇ÷ ¹× Ä¡·á¿ë Áֻ翡 ÀÇÇÑ ÇÕº´Áõ
T80.1
Vascular complications following infusion, transfusion and therapeutic injection
ÁÖÀÔ, ¼öÇ÷ ¹× Ä¡·á¿ë Áֻ翡 ÀÇÇÑ Ç÷°ü¼º ÇÕº´Áõ
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
ÄÚµå
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½